Detalhe da pesquisa
1.
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.
Blood
; 137(20): 2817-2826, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259589
2.
Geographic Patterns of Asthma Rates and Air Quality in Delaware.
Dela J Public Health
; 5(1): 30-38, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34467013